提炼
急性肺栓塞(PE) presen患者t with a spectrum of clinical severity and PE-related outcomes. In recent years, risk stratification based on clinical, biochemical and imaging features has been used to predict the risk of adverse events and determine optimal therapy for patients with PE. The European Society of Cardiology (ESC), in conjunction with the European Respiratory Society (ERS), published recent guidelines for the diagnosis and management of acute PE that support the use of stratification of patients into risk categories to determine the management strategy with an optimal risk–benefit ratio (class I, level B recommendation) [1]. Patients with PE who have haemodynamic instability have the highest risk of mortality and warrant urgent revascularisation. There is a large group of intermediate risk patients who are haemodynamically stable but have other risk features, such as significant tachycardia or right ventricular (RV) dysfunction, for which therapy beyond anticoagulation remains controversial. In contrast, patients who are haemodynamically stable with no high-risk features may be considered for oral anticoagulation and outpatient management [1].
抽象的
急性PE提早出院后,生活质量有所改善,但没有所有患者的生活质量。临床医生需要了解影响给定患者生活质量的因素,并且必须确定出院后需要更多支持的患者。https://bit.ly/35dwzgv
脚注
Conflict of interest: K. Solverson has nothing to disclose.
Conflict of interest: L. Skeith reports grants from CSL Behring, non-financial support from LEO Pharma, outside the submitted work.
Conflict of interest: J. Weatherald reports grants, personal fees and non-financial support from Janssen Inc. and from Actelion, personal fees and non-financial support from Bayer, personal fees from Novartis, outside the submitted work.
- 已收到October 12, 2020.
- 公认2020年10月13日。
- 版权所有©ERS 2021